Navigation Links
The Convergence of Art, Science and Beer
Date:6/22/2012

San Diego, California (PRWEB) June 22, 2012

Two things that both atheists and the devoutly religious can agree upon are that God created beer and that beer is good. (What? Yeah, we know. But we’re talking about beer here.) Yonder Biology believes that the yeasts used to make beer are often overlooked -- the forgotten heroes of beer. In homage, Yonder is employing its expertise in DNA analysis, design and beer drinking to create artistic representations of the yeasts used in brewing various styles beer.

In May 2012, Yonder Biology showcased its beer inspired DNA art work at Green Flash Brewery in San Diego with 'The DNA of Beer' exhibition. And this month (June 2012) Yonder Biology was commissioned to provide yeast DNA portraits for the new White Labs tasting room. “At first they didn’t believe us when we told them it takes a keg of beer to extract enough yeast DNA for our process… and they were right.” said Andy Bass, co-founder of Yonder Biology. “Still we found a way to make it work and were able to visualize cool differences in the various yeast strains.”

Yonder is expanding the DNA profiling of yeasts to characterize some of Americas’ favorite craft beers. In collaboration with local breweries Yonder will continue to shed more light upon their single celled eukaryotic brethren, Saccharomyces cerevisiae (common beer yeast). And for good measure Yonder established a functioning beer tap on the wall in the company’s DNA Art Gallery. Yonder patrons can now view and taste the art.

The Yonder Biology DNA Art Gallery is open Monday through Friday 11am to 7pm by appointment. Private parties are welcomed.

About Yonder

Yonder Biology, a DNA Art company with an art gallery and laboratory in San Diego, California, unites science and art. The DNA code is unique to each individu
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
2. Garage Start-ups Now Possible in Life Sciences Industry
3. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
4. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
5. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
6. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
7. BioSpace Spotlights Northwests Life Science Community
8. CNR Rao wins 2011 Ernesto Illy Trieste Science Prize
9. DiaTech Life Sciences Announces Medical Advisory Board
10. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
11. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Convergence of Art, Science and Beer
(Date:5/28/2015)... May 28, 2015 Glenn Keet, CEO ... Changing Landscape of EMR/EHR Clinical Data Integration with EDC ... place in Washington, DC on June 14th-18th. , During ... integrating EMR/EHR systems with EDC, and will examine the ... by eSource and electronic health records/electronic medical records integration. ...
(Date:5/28/2015)... Rochelle, Virginia (PRWEB) May 28, 2015 ... Partners LLC announced today that Roger L. Williams, ... Expert consultant. NDA Partners Premier Experts are top ... them to bring extraordinary value to the company’s ... critical solutions to help clients successfully develop their ...
(Date:5/27/2015)... RXi Pharmaceuticals Corporation (NASDAQ: RXII ... developing innovative therapies primarily in the areas of ... a public offering of shares of its common ... stock and overallotment purchase rights to purchase shares ... stock, warrants and overallotment purchase rights are immediately ...
(Date:5/27/2015)... May 27, 2015 Expanding in a ... manufacturer Avalon Biomed Inc. recently inked a ... Mokuda Dental Co. Ltd. , the largest endodontic distributor ... the international market for Avalon Biomed, which manufactures Grey ... tricalcium silicate-based dental cements that have won renown from ...
Breaking Biology Technology:Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3
... Sept. 7 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), ... wave of,antibody therapeutics, today announced that it will ... data for,two of its anti-cancer antibody drug candidates. ... San Francisco on September 7-8,Arius will report recent ...
... Belgium and LUND, Sweden, September 7 ... Into Phase,II Clinical Development ThromboGenics NV (Euronext ... and co-development partner, BioInvent,International (Nordic Exchange: BINV), announce ... follow-up of all volunteers,in the first Phase I ...
... and James Weaver as Chairman, WALTHAM, Mass., Sept. ... today that Thomas Gerson has been named Chief,Financial Officer. ... the Board of Directors. In addition, Nazneen Aziz has ... "We are pleased to welcome Tom to Interleukin," said ...
Cached Biology Technology:Arius Features Preclinical Data on Antibody Candidates at Two Conferences 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 3ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 2ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 3ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 4ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402 5Interleukin Genetics Announces Management and Board Appointments 2Interleukin Genetics Announces Management and Board Appointments 3Interleukin Genetics Announces Management and Board Appointments 4
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/18/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... and chemically modified graphene sheets in a wide variety ... of Texas at Austin engineering team led by Professor ... a host of important materials and applications such as ... plastic electronics. Graphene is a unique atom-thick, carbon-based ...
... help people who are not responding to Anti-Retroviral Therapy, ... of Immunology . Scientists looking at monkeys with the ... virus levels in the blood to undetectable levels, by ... Anti-Retroviral Therapy (ART). Simian Immunodeficiency Virus (SIV) is ...
... a common cause of back pain has picked up one ... research paper produced by the team of surgeons, engineers and ... of three categories of the annual ISSLS Prize for Lumbar ... Study of the Lumbar Spine (ISSLS), the accolade is designed ...
Cached Biology News:Engineers develop method to disperse chemically modified graphene in organic solvents 2Potential new HIV drug may help patients not responding to treatment 2Potential new HIV drug may help patients not responding to treatment 3International prize for Nottingham spine research 2
... (MSTA) slides were designed to study protein expression ... species. Tissue slices from three different species ... then be treated as a single histological slide ... hybridization. This format allows a rapid ...
... Pulser Xcell eukaryotic system, 100 ... is used for electroporation of ... the main unit, CE module ... or square-wave pulses, ShockPod shocking ...
... is used to predict the ... sequence up to 3,200 bases, ... of primers and GC clamps ... gradient gel electrophoresis (DGGE), constant ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
Biology Products: